BioMarin CEO replaces commercial chief—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
GSK PLC on Tuesday said the US Food & Drug Administration accepted its supplemental biologics licence application for endometrial cancer treatment dostarlimab, or Jemperli, after it was granted. | June 6, 2023
GSK PLC on Tuesday said the European Medicines Agency has validated its marketing authorisation application for its dostarlimab drug, marketed as Jemperli.
The London-based pharmaceutical firm said. | April 25, 2023